MTDDr. Mark T. Dransfield completed his MD degree at the University of North Carolina at Chapel Hill followed by residency in internal medicine and fellowship in pulmonary and critical care at the University of Alabama at Birmingham where he served as chief fellow. He has been on the faculty at UAB since 2003 and is currently Associate Professor of Medicine in the Division of Pulmonary, Allergy and Critical Care and also a staff physician at the Birmingham VA Medical Center. He serves as the Medical Director of the UAB Lung Health Center and the Medical Director of Pulmonary Rehabilitation. He was named Top 10 Teacher in the Department of Medicine in 2006-2008 and in 2009 was a recipient of the Cobbs-Rutsky Award for Clinical Excellence. He has been named one of America’s Best Doctors in 2010-2013. He has served on the ATS Clinical Problems Assembly Program Committee since 2008 and is also a member of the guideline development committee for the American College of Chest Physicians and Canadian Thoracic Society Evidence-based Guidelines for the Prevention of Acute Exacerbations.                  Full Manuscript pdf button

Dr. Dransfield’s primary clinical and research interest is chronic obstructive pulmonary disease (COPD). He has particular interest in the care of patients with advanced COPD and directs the UAB lung volume reduction surgery evaluation process and the UAB/Centers for Medicare and Medicaid COPD Integrated Practice Unit. He is Principal Investigator for multiple clinical trials at the UAB Lung Health Center (LHC) including the NIH sponsored COPD Clinical Research Network studies, COPDGene, and Spiromics as well as numerous phase II-IV pharma sponsored projects. As Medical Director of the LHC he also oversees multiple translational research projects focusing on airways disease. The LHC encompasses approximately 11,300 square feet of laboratory and clinical research space. The LHC is currently conducting more than 15 clinical trials in COPD and asthma and houses cores in Human Pulmonary Function, Recruitment, and Regulatory Support as well as a Biospecimen Repository and has collaborations on campus for the performance of research bronchoscopy, proteomics, synthetic chemistry, and murine pulmonary function testing and specimen analysis. He has published over 65 research papers focusing on COPD related epidemiology, co-morbid illness, pathophysiology and therapeutics.    Full Manuscript pdf button